Panacea Life Sciences Holdings Inc · OTC:PLSH
Panacea Life Sciences — Investor Presentation (June 2022)
28 slides from Panacea Life Sciences's investor presentation, Jun 10, 2022
Slide 1: Panacea Life Sciences Investor Presentation June 2022
panacealife.com | OTCQB: PLSH Panacea Life Sciences June 2022 Investor Presentation
Slide 2: Disclaimer
— Disclaimer This Presentation (the “Presentation”) has been prepared solely for informational purposes by Company and any individuals mentioned in the Presentation (together, “Company”) and is being furnished solely for use by prospective investors and other third parties in connection with their c
Slide 3: PLSH is an established seed-to-sale cannabinoid and manufacturing company
PLSH is an established seed-to-sale cannabinoid and manufacturing company — 50 PANA brand product lines Established retail, white label and contract manufacturing customer base Made in USA, Made in Colorado We are focused on the next stage of the company development leveraging scientific expertise,
Slide 4: Investment Highlights
Investment Highlights Fully-Integrated Cannabinoid Based Business Focused on providing portfolio of high-end products for humans and companion animals cGMP Manufacturing Facility Operating within State-of-the-art 51,000 sq.ft. facility Multiple Growth Opportunities Expand existing business, robust b
Slide 5: State-Of-The-Art 51,000 sq.ft. cGMP Manufacturing Facility
State-Of-The-Art 51,000 sq.ft. cGMP Manufacturing Facility Producing High Quality, Pharmaceutical Grade Products — Total capacity — Weekly CBD oil extraction and production capability — Daily softgel production — Liquid fills per day In-house bottling and labeling Fulfillment Services
Slide 6: Stringent In-House Quality Control
Stringent In-House Quality Control = Ge q vi D au! i ¥ 2 Test Seeds Receive Test Extract Test Process to Test Process to & Soil Hemp Hemp Crude Oil Crude Oil Distillate Distillate CBD Isolate Hho proFne | ! 2 yi A Test Seeds Develop Test Finalize Certificate Isolate Formulation Formulation Product o
Slide 7: Sales Channels and Market Accessibility
—— Sales Channels and Market Accessibility Online Direct to Consumers White Label/Contract Mfg. Retail/Wholesale ~35% of total sales ~45% of total sales ~20% of total sales Established online presence Trusted Manufacturing 1100 Retail locations Source Natural retail chains Direct to consumer eCommer
Slide 8: Fully Integrated SAP ERP System
—— Fully Integrated SAP ERP System FINANCE/ACCOUNTING | INVENTORY CONTROLS AND VENDOR MANAGEMENT HUMAN RESOURCES | PRODUCTION PLANNING Streamline Business Integrate Payroll and Provide Tracking of Production Costs Inventory Movement Monitoring Processes and Measurement Points PROVIDES PANACEA WITH T
Slide 9: The CBD Market Is Rapidly Expanding
—— The CBD Market Is Rapidly Expanding Establishing Leadership Position in New and Evolving CBD Market ~64 Million people have tried CBD in the last 24 months? S2.7 Billion market valued in 20202 $20 Billion market expected to surpass by 2024? 51% CARGR market expected to grow from 2021 to 20302 201
Slide 10: Growing a High-End Consumer Cannabinoid Brand
Growing a High-End Consumer Cannabinoid Brand Providing Solutions with an Emphasis on Quality, Purity and Benefits Health Beauty Sports Companion Raw Materials Animal
Slide 11: PANA HEALTH
—— PANA HEALTH’ Cannabinoid Products Designed to Support Everyday Wellness TOPICALS SOFTGELS TABLETS TINCTURES 11
Slide 12: PANA BEAUTY
—— PANA BEAUTY” High-End CBD Products To Support Healthier Skin Dermatologist Created and Approved PANA MOISTURIZING FACE MOISTURE ENAE SKIN CREAM CREAM THERAPY THERAPY CLEARING 12
Slide 13: PANA SPORT
—— PANA SPORT" Designed to Keep Athletes at Any Level At the Top of Their Game HEATING COOLING HEATING COOLING K STICK STICK PATCHES PATCHES TAPE Designed to Provide Long-Lasting Relief from Muscle and Joint Aches and Pains Y “ 13
Slide 14: PANA LIFE
—— PANA LIFE*® Daily CBD Wellness Gummies and Lip Balm GUMMIES GUMMIES LIP TO-GO SOOTHE 14
Slide 15: PANA PET
— PANA PET’ Aim To Relieve Joint Pain, Inflammation and Anxiety in Cats, Dogs and Horses OIL RELIEF EQUINE CALMOLYTE SOFUOELE DROPS CREAM MINT HORSE PASTE
Slide 16: PANA PURE
—— PANA PURE® CBD CRUDE | CBD DISTILLATE | DISTILLATE BLENDS | CBG | CBN | CBDA Hemp from Colorado based PANA Organic Botanicals at Needle Rock Tested for quality, potency and purity Pesticides, herbicides, heavy metals and microbials Grown in ideal environment with access to Rocky Mountain spring w
Slide 17: Proven Leadership Team
—— Proven Leadership Team Leslie Buttorff Chief Executive Officer & Chairman Over 35 years as a senior executive in management, marketing, engineering, and financial analyses at companies such as AT Kearny, Arthur D. Little, EDS (HP) and Perot Systems. BS Statistics and MS Industrial Administration.
Slide 18: Potential for Multiple Near-Term Growth Opportunities
Potential for Multiple Near-Term ~ Growth Opportunities Expand Current Business Leveraging Existing Assets Growth Through M&A Grow current brands through Sell excess cGMP Activity evaluating synergistic robust marketing efforts manufacturing capabilities acquisition targets Develop natural, purposef
Slide 19: Growing the Brand Through Robust Marketing Efforts
—— Growing the Brand Through Robust Marketing Efforts— Details Around Marketing Paid Advertising Campaigns Email Campaigns Social Athlete Influencers Influencers Paid SEO Social Media Instagram Twitter Facebook DMA Focused Trusted Personalities Tom Martino Tony Lombardi Tradeshows Cosmetic Industry
Slide 20: Significant Growth Opportunity in Nutraceuticals
— Significant Growth Opportunity in Nutraceuticals ———— 1. _ https://www.fortunebusinessinsights.com/nutraceuticals-market-102530 Consumers are actively searching for pharmaceutical alternatives with medical benefits $320 billion market expected to grow to $658 billion by 2028+ Gaining popularity wi
Slide 21: PANA Nutraceuticals
—— PANA Nutraceuticals® Purposeful Formulations Leveraging Science, Data and Expertise CANNABIDIOL CBDA PM SLEEP CBD+CBG ORAL SOLUTION OIL DROPS SOFTGELS DERMA SOOTHE Purposely formulated to help Supports your vital Fall asleep faster, and Reduce and soothe skin alleviate more long-term and immune s
Slide 22: Opportunity to Expand Into Complementary Verticals
—— Opportunity to Expand Into Complementary Verticals— Attack Adjacent Industries Current US Market Size (Billions of $) Personal care Packaged Food Pharmaceuticals Animal Feed Alcoholic Beverages Pet Food Tobacco Supplements Cannabis Seed = Personal care m Packaged Food Pharmaceuticals = Animal Fee
Slide 23: Proven Quality Through Data
—— Proven Quality Through bata____ @ Partnership with Colorado State University Unitizing data and proven expertise to develop new high-quality products Harnessing additionally hemp benefits through CBG, CBC, CBN, THCY, etc. Setting the industry quality standard through testing equipment and chromat
Slide 24: On-Going Research Studies for Pharmaceutical Alternatives
On-Going Research Studies for Pharmaceutical Alternatives Near-Term Opportunities to Provide Solutions in Areas of High-Value and Unmet Need Method Development: Removal of pesticides, isolation of CBDV, CBC Animal Studies Human Clinical Studies McGrath and Moreno (CSU): CBD and Reynolds (CSU) Crews
Slide 25: Development Timelines
—— Development Timelines Primary pharmacology of CBD/CBG/CBN Cannabinoid Cytokine Release Th17 Antimicrobial Study Follow on Gonorrhea Study Animal Studies Canine Dementia Juvenile Cattle Analgesia Human Studies Anxiety IBS Pharmacokinetics Chronic Pelvic Pain PROPOSAL SABEVALUATION —IRBAPPLICATION
Slide 26: Scientific Advisory Board
Scientific Advisory Board Nathan Morris, MD General Practitioner Highly regarded holistic doctor and actual customer of Panacea Janice Knox, MD General Practitioner Leading expert in Cannabis/Hemp Industry Paul Dean, MD Dermatologist ; Strategic Partner in the Personal Care f industry —— Advancement
Slide 27: Investment Summary
—— Investment Summary Emerging as a Leading Seed-to-Sale Cannabinoid Company Leveraging scientific innovation, research and data to provide high-quality, pharmaceutical grade products Growing a high-end consumer cannabinoid brand focused on quality, purity and benefits Unlocking potential value with
Slide 28: panacealife.com
panacealife.com | OTCQB: PLSH Panacea Life Sciences IR Contact: JTC Team, Inc. 833.475.8247 plsh@jtcir.com
Panacea Life Sciences Holdings — Investor Presentation (June 2022) on 6ix